You are here

Article info

Article menu

Download PDFPDF

XML
Research Article
Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC)

Authors

  • Daniel Carvajal-Hausdorf Department of PathologyYale School of Medicine New Haven USA Anatomia Patologica, Clinica AlemanaFacultad de Medicina Universidad del Desarrollo Santiago Chile PubMed articlesGoogle scholar articles
  • Mehmet Altan Medical OncologyYale School of Medicine and Yale Cancer Center 333 Cedar St. FMP117 06520-8023 New Haven CT USA Thoracic OncologyMD Anderson Cancer Center Camden USA PubMed articlesGoogle scholar articles
  • Vamsidhar Velcheti Thoracic OncologyNew York University New York USA PubMed articlesGoogle scholar articles
  • Scott N. Gettinger Medical OncologyYale School of Medicine and Yale Cancer Center 333 Cedar St. FMP117 06520-8023 New Haven CT USA PubMed articlesGoogle scholar articles
  • Roy S. Herbst Medical OncologyYale School of Medicine and Yale Cancer Center 333 Cedar St. FMP117 06520-8023 New Haven CT USA PubMed articlesGoogle scholar articles
  • David L. Rimm Department of PathologyYale School of Medicine New Haven USA Medical OncologyYale School of Medicine and Yale Cancer Center 333 Cedar St. FMP117 06520-8023 New Haven CT USA PubMed articlesGoogle scholar articles
  • Kurt A. Schalper Department of PathologyYale School of Medicine New Haven USA Anatomia Patologica, Clinica AlemanaFacultad de Medicina Universidad del Desarrollo Santiago Chile Medical OncologyYale School of Medicine and Yale Cancer Center 333 Cedar St. FMP117 06520-8023 New Haven CT USA PubMed articlesGoogle scholar articles

Citation

Carvajal-Hausdorf D, Altan M, Velcheti V, et al
Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC)
Journal for ImmunoTherapy of Cancer 2019;7:65. doi: 10.1186/s40425-019-0540-1
Online issue publication 
January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.